百赛诺(即双环醇)是我国自主研制的一类抗肝炎新药,自2001年上市以来已在数百家大中型医院临床应用并得到全国各地传染病专家的关心和支持。2002年10月27日由斯崇文教授主持,徐道振教授、刘耕陶院士为大家报告了有关百赛诺药理和临床研究的精华。北京协和药厂厂长瘐石山先生为大家介绍了百赛诺科研项目及经费的背景、申请流 As a new type of anti-hepatitis new drug developed independently by our country, Baiseno (now known as bicyclol) ​​has been used clinically in hundreds of large and medium-sized hospitals since it was launched in 2001 and has received the concern and support of infectious disease experts from all over the country. On October 27, 2002, chaired by Professor Chong-Wen Si, Professor Xu Daozhen and Liu Gengtao gave the best reports on the pharmacology and clinical research of Bio-Connaught. Mr. Xie Shishan, director of Beijing Xiehe Pharmaceutical Factory, introduced the background of the Baiseo scientific research project and funding, applied for the flow